Body Mass Index-Related Trends in Adverse Events with Enfortumab Vedotin: Analysis of a Pharmacovigilance Database and Medical Records
Motoki Kei, Shiori Sato, Ryosuke Yamaga, Satoko Karaki, Yoshihiro Uesawa, Toshimasa Ito · 2026
Read Body Mass Index-Related Trends in Adverse Events with Enfortumab Vedotin: Analysis of a Pharmacovigilance Database and Medical Records by Motoki Kei, Shiori Sato, Ryosuke Yamaga, Satoko Karaki, Yoshihiro Uesawa, Toshimasa Ito (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/openalex-w4416229476.txt.
Description
Motoki Kei, Shiori Sato, Ryosuke Yamaga, and colleagues study how body mass index relates to side effects of enfortumab vedotin. Their paper appeared in the Biological and Pharmaceutical Bulletin in 2026. The drug treats advanced bladder cancer. Skin problems are its troublesome side effect.
The team mined Japan's national side-effect database and checked hospital records. Heavier patients showed more skin disorders, itching, high blood sugar, and one severe skin reaction. Lighter patients showed more kidney infections instead. The hospital records linked skin toxicity to higher body weight and to larger doses per ideal weight. The authors urge dosing and risk checks fitted to each patient's build.
Catalog record
| CREATOR | Motoki Kei, Shiori Sato, Ryosuke Yamaga, Satoko Karaki, Yoshihiro Uesawa, Toshimasa Ito |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 58 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | OpenAlex / Biological and Pharmaceutical Bulletin |